The SGC catalyzes research in new areas of human biology and drug discovery by focusing explicitly on less well-studied areas of the human genome. The SGC accelerates research in these new areas by making all its research output available to the scientific community with no strings attached, and by creating an open collaborative network of scientists in hundreds of universities around the world and in eight global pharmaceutical companies.

Research

Structural Genomics Consortium

Aled Edwards

Max Morgan

Cheryl Arrowsmith

Michael Sundström

Timothy Willson

Stefan Knapp

Susan McCormick

The Structural Genomics Consortium (SGC) is an international, not-for-profit organization that is dedicated to solving the three-dimensional structures of proteins of therapeutic interest. The SGC was founded in 2001 by a group of scientists from academia and industry with the goal of making a significant impact on human health by providing the scientific community with tools and resources that would enable the structure-based design of new drugs. The SGC is headquartered in Toronto, Canada, with nodes in the United Kingdom, Sweden, Switzerland, and the United States. The SGC Board of Directors is composed of representatives from academia, industry, and government.

Board of Directors

Leadership Team

CEO and Executive Team

Board of Directors

About

Team members

Other teams at Structural Genomics Consortium

Leadership Team

CEO and Executive Team